Despite the best efforts of modern medicine, Huntington’s disease is a condition that still comes with a tragic prognosis.
Scientists at St. Jude Children's Research Hospital and Northwestern University identified a previously unknown treatment ...
2don MSN
First-in-human trial of CRISPR gene-editing therapy safely lowers cholesterol and triglycerides
In a 15-patient, Phase 1, first-in-human trial, a one-time CRISPR-Cas9 gene-editing therapy safely reduced LDL cholesterol ...
We have written about the promise of gene therapy to correct genetic disease many times. An exciting development happened ...
The alliance extends a deal streak in genetic medicine for Lilly and hands the company rights to an experimental treatment ...
Researchers report early but encouraging results on an experimental gene-editing treatment for high cholesterol.
In a phase 1 trial, a gene-editing therapy that targets ANGPTL3 was associated with few serious adverse events and at higher ...
In 1962, a pediatric neurology resident at Columbia's Neurological Institute and his colleagues in the College of Physicians ...
A single infusion of CRISPR Therapeutics' experimental gene therapy was safe and reduced levels of harmful LDL cholesterol ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback